WANAN YOSSINGKUM/iStock via Getty Images Gelteq ( NASDAQ: GELS ) priced its initial public offering of 1.3M ordinary shares at a public offering price of $4.00 per share.
Gelteq is a Melbourne, Australia headquartered global biotechnology company that specializes in the formulation, development, and manufacturing of an innovative ingestible gel platform designed for nutrient and.
Business